Affiliation:
1. Departments of Surgery
2. Microbiology and Immunology, Texas Tech University Health Sciences Center, Lubbock, Texas 79430
3. Titan Pharmaceuticals, Inc., South San Francisco, California 94080
Abstract
ABSTRACT
Gallium (Ga) is a semimetallic element that has demonstrated therapeutic and diagnostic-imaging potential in a number of disease settings, including cancer and infectious diseases. Gallium's biological actions stem from its ionic radius being almost the same as that of ferric iron (Fe
3+
), whereby it can replace iron (Fe) in Fe
3+
-dependent biological systems, such as bacterial and mammalian Fe transporters and Fe
3+
-containing enzymes. Unlike Fe
3+
, ionic gallium (Ga
3+
) cannot be reduced, and when incorporated, it inactivates Fe
3+
-dependent reduction and oxidation processes that are necessary for bacterial and mammalian cell proliferation. Most pathogenic bacteria require Fe for growth and function, and the availability of Fe in the host or environment can greatly enhance virulence. We examined whether gallium maltolate (GaM), a novel formulation of Ga, had antibacterial activity in a thermally injured acute infection mouse model. Dose-response studies indicated that a GaM dose as low as 25 mg/kg of body weight delivered subcutaneously was sufficient to provide 100% survival in a lethal
P. aeruginosa
-infected thermally injured mouse model. Mice treated with 100 mg/kg GaM had undetectable levels of
Pseudomonas aeruginosa
in their wounds, livers, and spleens, while the wounds of untreated mice were colonized with over 10
8
P. aeruginosa
CFU/g of tissue and their livers and spleens were colonized with over 10
5
P. aeruginosa
CFU/g of tissue. GaM also significantly reduced the colonization of
Staphylococcus aureus
and
Acinetobacter baumannii
in the wounds of thermally injured mice. Furthermore, GaM was also therapeutically effective in preventing preestablished
P. aeruginosa
infections at the site of the injury from spreading systemically. Taken together, our data suggest that GaM is potentially a novel antibacterial agent for the prevention and treatment of wound infections following thermal injury.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference38 articles.
1. Burn incidence and treatment in the US: fact sheet. 2007
2. Current protocols in molecular biology. 1988
3. Bernstein, L. R. 1998. Mechanisms of therapeutic activity for gallium. Pharmacol. Rev.50:665-682.
4. Bernstein, L. R., T. Tanner, C. Godfrey, and B. Noll. 2000. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Met.-Based Drugs7:33-47.
5. Bild, D. E., J. V. Selby, P. Sinnock, W. S. Browner, P. Braveman, and J. A. Showstack. 1989. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care12:24-31.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献